Trexquant Investment LP Bio Atla, Inc. Transaction History

Trexquant Investment LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.13 - $5.38 $245,727 - $620,663	-115,365 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.38 - $18.78 $421,758 - $1.81 Million	96,292 Added 504.86%	115,365 $577,000
Q4 2021 Feb 14, 2022	BUY	$19.0 - $30.95 $78,470 - $127,823	4,130 Added 27.64%	19,073 $374,000
Q3 2021 Nov 12, 2021	BUY	$29.44 - $43.74 $439,921 - $653,606	14,943 New	14,943 $440,000

17.4M

500

33.5K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $25M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.